Advantages offered by multiplex PCR over singleplex PCR is the factors basically driving the multiplex PCR market. The usage of multiplex PCR in determination of pathogenic mutations in reproductive genetic testing has been increasing since the last few years. The capillary electrophoresis-based multiplex PCR assay has demonstrated specificity, sensitivity, and precision in detection of specified variants.
The companies operating in the multiplex PCR market are working toward establishing a multiplex RT-PCR method to detect porcine astroviruses’ five known genotypes. They are also exploring the usage of novel multiplex-PCR test for Escherichia coli detection. Study is being conducted regarding devising a smart-plexer, which is bound to be one of the breakthrough workflows for hybrid progression of multiplex PCR assays.
A polymerase chain reaction (PCR) is referred to as an amplification technique broadly used for rapidly making innumerable copies of an exclusive DNA sample.
A primer is needed for adding the first nucleotide, as polymerase enzyme can start making novel complementary DNA stand only after binding of the primer. It could thus be inferred that primers act as starting point regarding DNA synthesis.
Multiplexing means processing of multiple samples at the same time, generally for saving money and time. Multiplex PCR is a technique in which numerous DNA sequences are amplified using PCR. In other words, it is a type of target enrichment approach.
| Attribute | Detail |
|---|---|
| Market Drivers |
|
Multiplex assays, as compared to singleplex assays such as ELISA or western blot, facilitate acquisition of more data from samples. The ability of evaluating multiple analytes simultaneously translates into reduction of procedure times along with saving on cost and time.
Multiplex immunoassays offer a higher efficiency at reduced price as compared to singleplex assays. They are reported to provide a higher output per sample volume ratios. The throughput is also higher, which indicates more resolute.
Multiplex assays are broadly employed in diagnostics and catalyze R&D of personalized medicine.
Advantages offered by multiplex PCR is thus accelerating the multiplex PCR market.
Multiplex PCR has more than one target sequence amplified by inclusion of over one pair of primers in the reaction.
Multiplex PCR is being increasingly used for nucleic acid diagnostics including mutation and polymorphism, mutation analysis, gene deletion analysis, RNA detection, and quantitative analysis.
Multiplex PCR is also reported to be one of the valuable methods to identify bacteria, viruses, fungi, and/or parasites.
Simultaneous amplification and differentiation of various symptoms is saving on time as well efforts. Along these lines, in January 2022, Health Canada approved SARS CoV-2 FluA/FluB/RSV assay from Seegene’s Allplex, one of the multiplex real-time PCR assays designed for facilitating speedy amplification as well as differentiation of the respiratory symptoms.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
As per the latest multiplex PCR market analysis, North America dominated the multi-target PCR landscape in 2023 and the scenario is expected to remain the same during the forecast period. This is attributed to growing incidence of chronic disorders such as cancer and stroke coupled with increase in funds provided by the governments for detecting new biomarkers. In April 2022, Bruker Corporation introduced an exclusive LiquidArray multiplex PCR assay capable of detecting seven major pathogens responsible for sexually transmitted infections (STIs).
Asia Pacific’s significant multiplex PCR market share is ascribed to the key players entering into collaborative agreements for developing multiplexing capacities. For instance, in November 2021, QuantuMDx inked an agreement with Sansure Biotech for developing multiplexing capacities in China. It received grant of US$ 10.9 Mn from Vita Spring in this regard.
The key players in the multiplex PCR market are resorting to inorganic modes of expansion to strengthen their position. For instance, in February 2021, Thermo Fisher completed acquisition of Mesa Biotech, whose Accula System is dedicated toward Covid-19 testing.
The companies are also launching new products followed by speedy approvals. For instance, in August 2021, Roche received approval from the U.S. FDA for companion diagnostics in order to detect dMMR solid tumors for patients suited to anti-PD-1 immunotherapy.
Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., QIAGEN N.V., Luminex Corporation, Standard BioTools Inc., BioFire Diagnostics, Becton, Dickinson and Company, DiaSorin, Seegene Inc, and Illumina, Inc. are some of the key players covered in the multiplex PCR market report.
These companies have been profiled based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Size in 2023 | US$ 2.7 Bn |
| Market Forecast (Value) in 2034 | US$ 6.4 Bn |
| Growth Rate (CAGR) | 8.2% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available Upon Request |
| Pricing | Available Upon Request |
It was valued at US$ 2.7 Bn in 2023.
It is projected to grow at a CAGR of 8.2% from 2024 to 2034.
Growing advantages of multiplex assays over conventional and singleplex assays and need for speedy laboratory systems with higher throughput.
Biopharmaceutical companies segment accounted for the largest share in 2023.
North America was the dominant region in 2023.
Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., QIAGEN N.V., Luminex Corporation, Standard BioTools Inc., BioFire Diagnostics, Becton, Dickinson and Company, DiaSorin, Seegene Inc, and Illumina, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Multiplex PCR Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Multiplex PCR Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Multiplex PCR Market Analysis and Forecast, by Products & Services
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Products & Services, 2020-2034
6.3.1. Consumables
6.3.2. Instruments
6.3.3. Software’s and Services
6.4. Market Attractiveness, by Products & Services
7. Global Multiplex PCR Market Analysis and Forecast, by Assay Type
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Assay Type, 2020-2034
7.3.1. Planar Assay
7.3.1.1. Blends Protein Assays (Multiplexed ELISA)
7.3.1.2. Antibody Assays
7.3.2. Bead-based Assay
7.3.2.1. Magnetic Bead-based
7.3.2.2. Non-Magnetic Bead-based
7.3.3. 7.4 Market Attractiveness, by Assay Type
8. Global Multiplex PCR Market Analysis and Forecast, by Application
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application, 2020-2034
8.3.1. Disease Diagnosis
8.3.2. Research & Development
8.3.3. Others (Clinical Diagnostics, etc.)
8.4. Market Attractiveness, by Application
9. Global Multiplex PCR Market Analysis and Forecast, by End-user
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2020-2034
9.3.1. Biopharmaceutical Companies
9.3.2. Clinical Research Organizations
9.3.3. Academic Research Institutes
9.3.4. Others (Diagnostic Centers, etc.)
9.4. Market Attractiveness, by End-user
10. Global Multiplex PCR Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2020-2034
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region
11. North America Multiplex PCR Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Products & Services, 2020-2034
11.2.1. Consumables
11.2.2. Instruments
11.2.3. Software’s and Services
11.3. Market Attractiveness, by Products & Services
11.4. Market Value Forecast, by Assay Type, 2020-2034
11.4.1. Planar Assay
11.4.1.1. Blends Protein Assays (Multiplexed ELISA)
11.4.1.2. Antibody Assays
11.4.2. Bead-based Assay
11.4.2.1. Magnetic Bead-based
11.4.2.2. Non-Magnetic Bead-based
11.5. Market Attractiveness, by Assay Type
11.6. Market Value Forecast, by Application, 2020-2034
11.6.1. Disease Diagnosis
11.6.2. Research & Development
11.6.3. Others (Clinical Diagnostics, etc.)
11.7. Market Attractiveness, by Application
11.8. Market Value Forecast, by End-user, 2020-2034
11.8.1. Biopharmaceutical Companies
11.8.2. Clinical Research Organizations
11.8.3. Academic Research Institutes
11.8.4. Others (Diagnostic Centers, etc.)
11.9. Market Attractiveness, by End-user
11.10. Market Value Forecast, by Country/Sub-region, 2020-2034
11.10.1. U.S.
11.10.2. Canada
11.11. Market Attractiveness Analysis
11.11.1. By Products & Services
11.11.2. By Assay Type
11.11.3. By Application
11.11.4. By End-user
11.11.5. By Country
12. Europe Multiplex PCR Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Products & Services, 2020-2034
12.2.1. Consumables
12.2.2. Instruments
12.2.3. Software’s and Services
12.3. Market Attractiveness, by Products & Services
12.4. Market Value Forecast, by Assay Type, 2020-2034
12.4.1. Planar Assay
12.4.1.1. Blends Protein Assays (Multiplexed ELISA)
12.4.1.2. Antibody Assays
12.4.2. Bead-based Assay
12.4.2.1. Magnetic Bead-based
12.4.2.2. Non-Magnetic Bead-based
12.5. Market Attractiveness, by Assay Type
12.6. Market Value Forecast, by Application, 2020-2034
12.6.1. Disease Diagnosis
12.6.2. Research & Development
12.6.3. Others (Clinical Diagnostics, etc.)
12.7. Market Attractiveness, by Application
12.8. Market Value Forecast, by End-user, 2020-2034
12.8.1. Biopharmaceutical Companies
12.8.2. Clinical Research Organizations
12.8.3. Academic Research Institutes
12.8.4. Others (Diagnostic Centers, etc.)
12.9. Market Attractiveness, by End-user
12.10. Market Value Forecast, by Country/Sub-region, 2020-2034
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
12.11.1. By Products & Services
12.11.2. By Assay Type
12.11.3. By Application
12.11.4. By End-user
12.11.5. By Country/Sub-region
13. Asia Pacific Multiplex PCR Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Products & Services, 2020-2034
13.2.1. Consumables
13.2.2. Instruments
13.2.3. Software’s and Services
13.3. Market Attractiveness, by Products & Services
13.4. Market Value Forecast, by Assay Type, 2020-2034
13.4.1. Planar Assay
13.4.1.1. Blends Protein Assays (Multiplexed ELISA)
13.4.1.2. Antibody Assays
13.4.2. Bead-based Assay
13.4.2.1. Magnetic Bead-based
13.4.2.2. Non-Magnetic Bead-based
13.5. Market Attractiveness, by Assay Type
13.6. Market Value Forecast, by Application, 2020-2034
13.6.1. Disease Diagnosis
13.6.2. Research & Development
13.6.3. Others (Clinical Diagnostics, etc.)
13.7. Market Attractiveness, by Application
13.8. Market Value Forecast, by End-user, 2020-2034
13.8.1. Biopharmaceutical Companies
13.8.2. Clinical Research Organizations
13.8.3. Academic Research Institutes
13.8.4. Others (Diagnostic Centers, etc.)
13.9. Market Attractiveness, by End-user
13.10. Market Value Forecast, by Country/Sub-region, 2020-2034
13.10.1. China
13.10.2. Japan
13.10.3. India
13.10.4. Australia & New Zealand
13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
13.11.1. By Products & Services
13.11.2. By Assay Type
13.11.3. By Application
13.11.4. By End-user
13.11.5. By Country/Sub-region
14. Latin America Multiplex PCR Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Products & Services, 2020-2034
14.2.1. Consumables
14.2.2. Instruments
14.2.3. Software’s and Services
14.3. Market Attractiveness, by Products & Services
14.4. Market Value Forecast, by Assay Type, 2020-2034
14.4.1. Planar Assay
14.4.1.1. Blends Protein Assays (Multiplexed ELISA)
14.4.1.2. Antibody Assays
14.4.2. Bead-based Assay
14.4.2.1. Magnetic Bead-based
14.4.2.2. Non-Magnetic Bead-based
14.5. Market Attractiveness, by Assay Type
14.6. Market Value Forecast, by Application, 2020-2034
14.6.1. Disease Diagnosis
14.6.2. Research & Development
14.6.3. Others (Clinical Diagnostics, etc.)
14.7. Market Attractiveness, by Application
14.8. Market Value Forecast, by End-user, 2020-2034
14.8.1. Biopharmaceutical Companies
14.8.2. Clinical Research Organizations
14.8.3. Academic Research Institutes
14.8.4. Others (Diagnostic Centers, etc.)
14.9. Market Attractiveness, by End-user
14.10. Market Value Forecast, by Country/Sub-region, 2020-2034
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
14.11.1. By Products & Services
14.11.2. By Assay Type
14.11.3. By Application
14.11.4. By End-user
14.11.5. By Country/Sub-region
15. Middle East & Africa Multiplex PCR Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Products & Services, 2020-2034
15.2.1. Consumables
15.2.2. Instruments
15.2.3. Software’s and Services
15.3. Market Attractiveness, by Products & Services
15.4. Market Value Forecast, by Assay Type, 2020-2034
15.4.1. Planar Assay
15.4.1.1. Blends Protein Assays (Multiplexed ELISA)
15.4.1.2. Antibody Assays
15.4.2. Bead-based Assay
15.4.2.1. Magnetic Bead-based
15.4.2.2. Non-Magnetic Bead-based
15.5. Market Attractiveness, by Assay Type
15.6. Market Value Forecast, by Application, 2020-2034
15.6.1. Disease Diagnosis
15.6.2. Research & Development
15.6.3. Others (Clinical Diagnostics, etc.)
15.7. Market Attractiveness, by Application
15.8. Market Value Forecast, by End-user, 2020-2034
15.8.1. Biopharmaceutical Companies
15.8.2. Clinical Research Organizations
15.8.3. Academic Research Institutes
15.8.4. Others (Diagnostic Centers, etc.)
15.9. Market Attractiveness, by End-user
15.10. Market Value Forecast, by Country/Sub-region, 2020-2034
15.10.1. GCC Countries
15.10.2. South Africa
15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
15.11.1. By Products & Services
15.11.2. By Assay Type
15.11.3. By Application
15.11.4. By End-user
15.11.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2023)
16.3. Company Profiles
16.3.1. Thermo Fisher Scientific
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Bio-Rad Laboratories, Inc.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. QIAGEN N.V.
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Luminex Corporation
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Standard BioTools Inc.
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. BioFire Diagnostics
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Becton, Dickinson and Company
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. DiaSorin
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Seegene Inc
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Illumina, Inc.
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
List of Tables
Table 01: Global Multiplex PCR Market Size (US$ Bn) Forecast, by Products & Services, 2020-2034
Table 02: Global Multiplex PCR Market Size (US$ Bn) Forecast, by Assay Type, 2020-2034
Table 03: Global Multiplex PCR Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 04: Global Multiplex PCR Market Size (US$ Bn) Forecast, by Application, 2020-2034
Table 05: Global Multiplex PCR Market Size (US$ Bn) Forecast, by Region, 2020-2034
Table 06: North America Multiplex PCR Market Size (US$ Bn) Forecast, by Country, 2020-2034
Table 07: North America Multiplex PCR Market Size (US$ Bn) Forecast, by Products & Services, 2020-2034
Table 08: North America Multiplex PCR Market Size (US$ Bn) Forecast, by Assay Type, 2020-2034
Table 9: North America Multiplex PCR Market Size (US$ Bn) Forecast, by Application, 2020-2034
Table 10: North America Multiplex PCR Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 11: Europe Multiplex PCR Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 12: Europe Multiplex PCR Market Size (US$ Bn) Forecast, by Products & Services, 2020-2034
Table 13: Europe Multiplex PCR Market Size (US$ Bn) Forecast, by Assay Type, 2020-2034
Table 14: Europe Multiplex PCR Market Size (US$ Bn) Forecast, by Application, 2020-2034
Table 15: Europe Multiplex PCR Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 16: Asia Pacific Multiplex PCR Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 17: Asia Pacific Multiplex PCR Market Size (US$ Bn) Forecast, by Products & Services, 2020-2034
Table 18: Asia Pacific Multiplex PCR Market Size (US$ Bn) Forecast, by Assay Type, 2020-2034
Table 19: Asia Pacific Multiplex PCR Market Size (US$ Bn) Forecast, by Application, 2020-2034
Table 20: Asia Pacific Multiplex PCR Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 21: Latin America Multiplex PCR Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 22: Latin America Multiplex PCR Market Size (US$ Bn) Forecast, by Products & Services, 2020-2034
Table 23: Latin America Multiplex PCR Market Size (US$ Bn) Forecast, by Assay Type, 2020-2034
Table 24: Latin America Multiplex PCR Market Size (US$ Bn) Forecast, by Application, 2020-2034
Table 25: Latin America Multiplex PCR Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 26: Middle East & Africa Multiplex PCR Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 27: Middle East & Africa Multiplex PCR Market Size (US$ Bn) Forecast, by Products & Services, 2020-2034
Table 28: Middle East & Africa Multiplex PCR Market Size (US$ Bn) Forecast, by Assay Type, 2020-2034
Table 29: Middle East & Africa Multiplex PCR Market Size (US$ Bn) Forecast, by Application, 2020-2034
Table 30: Middle East & Africa Multiplex PCR Market Size (US$ Bn) Forecast, by End-user, 2020-2034
List of Figures
Figure 01: Global Multiplex PCR Market Size (US$ Bn), by Region, 2023 and 2034
Figure 02: Global Multiplex PCR Market Revenue (US$ Bn), by Products & Services, 2023
Figure 03: Global Multiplex PCR Market Value Share, by Products & Services, 2023
Figure 04: Global Multiplex PCR Market Revenue (US$ Bn), by Assay Type, 2023
Figure 05: Global Multiplex PCR Market Value Share, by Assay Type, 2023
Figure 06: Global Multiplex PCR Market Revenue (US$ Bn), by Application, 2023
Figure 07: Global Multiplex PCR Market Value Share, by Application, 2023
Figure 08: Global Multiplex PCR Market Revenue (US$ Bn), by End-user, 2023
Figure 09: Global Multiplex PCR Market Value Share, by End-user, 2023
Figure 10: Global Multiplex PCR Market Value Share, by Region, 2023
Figure 11: Global Multiplex PCR Market Value (US$ Bn) Forecast, 2020-2034
Figure 12: Global Multiplex PCR Market Value Share Analysis, by Products & Services, 2023 and 2034
Figure 13: Global Multiplex PCR Market Attractiveness Analysis, by Products & Services, 2024-2034
Figure 14: Global Multiplex PCR Market Value Share Analysis, by Assay Type, 2023 and 2034
Figure 15: Global Multiplex PCR Market Attractiveness Analysis, by Assay Type, 2024-2034
Figure 16: Global Multiplex PCR Market Value Share Analysis, by Application, 2023 and 2034
Figure 17: Global Multiplex PCR Market Attractiveness Analysis, by Application, 2024-2034
Figure 18: Global Multiplex PCR Market Revenue (US$ Bn), by End-user, 2023
Figure 19: Global Multiplex PCR Market Value Share, by End-user, 2023
Figure 20: Global Multiplex PCR Market Value Share Analysis, by Region, 2023 and 2034
Figure 21: Global Multiplex PCR Market Attractiveness Analysis, by Region, 2024-2034
Figure 22: North America Multiplex PCR Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 23: North America Multiplex PCR Market Attractiveness Analysis, by Country, 2024-2034
Figure 24: North America Multiplex PCR Market Value Share Analysis, by Country, 2023 and 2034
Figure 25: North America Multiplex PCR Market Value Share Analysis, by Products & Services, 2023 and 2034
Figure 26: North America Multiplex PCR Market Value Share Analysis, by Assay Type, 2023 and 2034
Figure 27: North America Multiplex PCR Market Value Share Analysis, by Application, 2023 and 2034
Figure 28: North America Multiplex PCR Market Value Share Analysis, by End-user, 2023 and 2034
Figure 29: North America Multiplex PCR Market Attractiveness Analysis, by Products & Services, 2024-2034
Figure 30: North America Multiplex PCR Market Attractiveness Analysis, by Assay Type, 2024-2034
Figure 31: North America Multiplex PCR Market Attractiveness Analysis, by Application, 2024-2034
Figure 32: North America Multiplex PCR Market Attractiveness Analysis, by End-user, 2024-2034
Figure 33: Europe Multiplex PCR Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 34: Europe Multiplex PCR Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 35: Europe Multiplex PCR Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 36: Europe Multiplex PCR Market Value Share Analysis, by Products & Services, 2023 and 2034
Figure 37: Europe Multiplex PCR Market Value Share Analysis, by Assay Type, 2023 and 2034
Figure 38: Europe Multiplex PCR Market Value Share Analysis, by Application, 2023 and 2034
Figure 39: Europe Multiplex PCR Market Value Share Analysis, by End-user, 2023 and 2034
Figure 40: Europe Multiplex PCR Market Attractiveness Analysis, by Products & Services, 2024-2034
Figure 41: Europe Multiplex PCR Market Attractiveness Analysis, by Assay Type, 2024-2034
Figure 42: Europe Multiplex PCR Market Attractiveness Analysis, by Application, 2024-2034
Figure 43: Europe Multiplex PCR Market Attractiveness Analysis, by End-user, 2024-2034
Figure 44: Asia Pacific Multiplex PCR Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 45: Asia Pacific Multiplex PCR Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 46: Asia Pacific Multiplex PCR Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 47: Asia Pacific Multiplex PCR Market Value Share Analysis, by Products & Services, 2023 and 2034
Figure 48: Asia Pacific Multiplex PCR Market Value Share Analysis, by Assay Type, 2023 and 2034
Figure 49: Asia Pacific Multiplex PCR Market Value Share Analysis, by Application, 2023 and 2034
Figure 50: Asia Pacific Multiplex PCR Market Value Share Analysis, by End-user, 2023 and 2034
Figure 51: Asia Pacific Multiplex PCR Market Attractiveness Analysis, by Products & Services, 2024-2034
Figure 52: Asia Pacific Multiplex PCR Market Attractiveness Analysis, by Assay Type, 2024-2034
Figure 53: Asia Pacific Multiplex PCR Market Attractiveness Analysis, by Application, 2024-2034
Figure 54: Asia Pacific Multiplex PCR Market Attractiveness Analysis, by End-user, 2023–2034
Figure 55: Latin America Multiplex PCR Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 56: Latin America Multiplex PCR Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 57: Latin America Multiplex PCR Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 58: Latin America Multiplex PCR Market Value Share Analysis, by Products & Services, 2023 and 2034
Figure 59: Latin America Multiplex PCR Market Value Share Analysis, by Assay Type, 2023 and 2034
Figure 60: Latin America Multiplex PCR Market Value Share Analysis, by Application, 2023 and 2034
Figure 61: Latin America Multiplex PCR Market Value Share Analysis, by End-user, 2023 and 2034
Figure 62: Latin America Multiplex PCR Market Attractiveness Analysis, by Products & Services, 2024-2034
Figure 63: Latin America Multiplex PCR Market Attractiveness Analysis, by Assay Type, 2024-2034
Figure 64: Latin America Multiplex PCR Market Attractiveness Analysis, by Application, 2024-2034
Figure 65: Latin America Multiplex PCR Market Attractiveness Analysis, by End-user, 2024-2034
Figure 66: Middle East & Africa Multiplex PCR Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 67: Middle East & Africa Multiplex PCR Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 68: Middle East & Africa Multiplex PCR Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 69: Middle East & Africa Multiplex PCR Market Value Share Analysis, by Products & Services, 2023 and 2034
Figure 70: Middle East & Africa Multiplex PCR Market Value Share Analysis, by Assay Type, 2023 and 2034
Figure 71: Middle East & Africa Multiplex PCR Market Value Share Analysis, by Application, 2023 and 2034
Figure 72: Middle East & Africa Multiplex PCR Market Value Share Analysis, by End-user, 2023 and 2034
Figure 73: Middle East & Africa Multiplex PCR Market Attractiveness Analysis, by Products & Services, 2024-2034
Figure 74: Middle East & Africa Multiplex PCR Market Attractiveness Analysis, by Assay Type, 2024-2034
Figure 75: Middle East & Africa Multiplex PCR Market Attractiveness Analysis, by Application, 2024-2034
Figure 76: Middle East & Africa Multiplex PCR Market Attractiveness Analysis, by End-user, 2024-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Multiplex PCR Market
